CRISPR Therapeutics AG ($CRSP) Stock Forecast: Down 7.5% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics (CRSP) operates in the biotechnology sector, specializing in gene editing technologies. Today, market sentiment towards CRSP has been bearish.

Why is CRISPR Therapeutics AG going down?

CRSP stock is down 7.5% on Jul 29, 2025 13:56

• Investor caution may be linked to CRISPR Therapeutics' upcoming Q2 earnings report, with focus on Casgevy sales growth and advancements in its gene-editing pipeline.
• The decline in stock value could stem from traders taking profits, particularly following a recent market uptrend, suggesting a short-term adjustment.
• Market dynamics may also be influenced by general market trends or industry-specific developments affecting biotechnology stocks, contributing to the bearish sentiment surrounding CRSP today.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?

CRSP investors await the company's Q2 results with a focus on Casgevy sales growth and updates on gene-editing pipeline progress.

https://www.zacks.com/stock/news/2629129/crispr-therapeutics-to-report-q2-earnings-whats-in-the-cards

CRISPR Therapeutics AG ( CRSP ) Stock Slides as Market Rises: Facts to Know Before You Trade

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $66.06, moving 3.05% from the previous trading session.

https://www.zacks.com/stock/news/2614485/crispr-therapeutics-ag-crsp-stock-slides-as-market-rises-facts-to-know-before-you-trade

Trending Today

Ethena ($ENA) Crypto Forecast: Down 5.2% Today

Newell Brands Inc. ($NWL) Stock Forecast: Down 15.8% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Down 5.1% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 5.3% Today

MicroStrategy ($MSTR) Stock Forecast: Down 7.8% Today

Moderna Inc. ($MRNA) Stock Forecast: Down 9.9% Today

Roku Inc. ($ROKU) Stock Forecast: Down 14.6% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 8.3% Today

Illumina Inc. ($ILMN) Stock Forecast: Down 8.7% Today

Reddit Inc ($RDDT) Stock Forecast: Up 21.6% Today

CRISPR Therapeutics AG Price History

11.06.2025 - CRSP Stock was down 5.2%

• Despite recent positive developments for CRISPR Therapeutics, including promising early data for CTX310, the stock saw a downward trend today.
• Increased trading volume and share price fluctuations may have triggered profit-taking among investors, leading to the stock's decline.
• Analyst ratings varying widely and a broad price target range could have contributed to uncertainty and volatility in the stock's performance.
• External factors such as overall market conditions or sector-specific influences might have also impacted CRSP's decrease, with the stock ending lower than the previous close with a -1.88% change.

11.05.2025 - CRSP Stock was down 5.2%

• The bearish movement in CRSP stock today can be attributed to the following factors:
• Despite the overall bullish market sentiment, CRSP experienced a significant drop, indicating potential profit-taking by investors.
• The stock may have been overbought recently, leading to a correction in its price.
• Challenges in regulatory issues or setbacks in the development of CRISPR-based therapies could have spooked investors, causing a sell-off in the stock.
• Technical indicators may have signaled a bearish trend, prompting traders to sell their positions in CRSP.

09.06.2025 - CRSP Stock was up 5.4%

• CRSP stock exhibited a noteworthy bullish surge, defying the general market trend.
• The surge in stock value could be linked to favorable developments within the company, potentially associated with advancements in its gene-editing technology.
• Despite the market experiencing a downturn, CRSP remained resilient, underscoring strong investor confidence in the company's future trajectory.
• The optimistic outlook toward groundbreaking technologies and advancements in biotech, as evidenced by ARKK reaching a 52-week peak, likely played a role in the surge of CRSP stock.

30.05.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) saw a significant bullish movement today, closing at $47.66, up 1.88% from the previous trading session.
• The stock outperformed the market, finishing at $46.78, reflecting a +2.7% change from the day before.
• The positive momentum may be linked to increasing investor confidence in CRISPR technology and its potential applications in gene-based medicine.
• The company's recent progress in its research and development pipeline could also be influencing the positive sentiment surrounding the stock.

29.06.2025 - CRSP Stock was down 7.5%

• Investor caution may be linked to CRISPR Therapeutics' upcoming Q2 earnings report, with focus on Casgevy sales growth and advancements in its gene-editing pipeline.
• The decline in stock value could stem from traders taking profits, particularly following a recent market uptrend, suggesting a short-term adjustment.
• Market dynamics may also be influenced by general market trends or industry-specific developments affecting biotechnology stocks, contributing to the bearish sentiment surrounding CRSP today.

07.04.2025 - CRSP Stock was down 5.6%

• The company reported a wider-than-expected first-quarter loss and revenues that missed estimates, resulting in a 12% decline in the stock price.
• Despite a slight advance in the most recent trading session, CRSP underperformed the overall market, revealing weakness in the stock.
• The disappointing Q1 earnings and sales figures are likely key factors in the bearish movement of CRSP's stock price today.
• Investors may have concerns about the company's financial performance and future growth prospects, prompting a sell-off of CRSP shares.

25.06.2025 - CRSP Stock was down 5.2%

• Factors contributing to the downward movement in CRSP stock include:
• Despite the market's upward trajectory, CRSP stock experienced a decline, suggesting investor profit-taking.
• The 3.05% decrease in CRSP's stock price may be linked to overall market instability affecting biotech companies.
• Investors' actions may be influenced by recent developments concerning CRISPR Therapeutics AG, leading to a sell-off of the stock.

06.04.2025 - CRSP Stock was down 5.7%

• Despite the overall market performing well, CRSP underperformed.
• The slight increase in stock price from the previous trading session was not enough to offset the bearish trend.
• Potential factors such as negative news, profit-taking, or market sentiment towards the biotech sector could have contributed to the bearish movement.
• Investors might be cautious about the company's future prospects or regulatory challenges in the gene editing industry.

08.06.2025 - CRSP Stock was up 5.2%

• The bearish movement in CRSP stock can be attributed to:
• Profit-taking by investors following a recent uptrend in the stock price
• General market volatility resulted in a pullback in high-growth biotech stocks
• Potential concerns or uncertainties about the company's pipeline or future prospects

10.06.2025 - CRSP Stock was up 5.7%

• CRISPR Therapeutics (CRSP) saw a strong bullish movement today, with shares surging by 9.6%.
• The surge in CRSP's shares could be attributed to higher than average trading volume and positive market sentiment.
• Despite concerns about the latest trend in earnings estimate revisions not translating into further price increase in the near term, investors showed confidence in the stock.
• The negative sentiment in the broader market did not impact CRSP's performance, indicating strong investor interest in the company's innovative biotech solutions.

18.06.2025 - CRSP Stock was up 15.0%

• Key points for the bearish movement in CRSP stock:
• CRSP declining more than the overall market, indicating specific company-related factors at play.
• Investors might have reacted negatively to certain information or developments within the company.
• The -6.54% drop in CRSP's stock price could have triggered profit-taking or stop-loss orders, further exacerbating the decline.
• It is essential for investors to closely monitor any news or updates from CRISPR Therapeutics AG to make informed decisions regarding their investments in the company.

24.05.2025 - CRSP Stock was up 5.2%

• CRSP stock price increased by 2.87% despite a market slip.
• The bullish movement could be attributed to positive news or developments related to CRISPR Therapeutics AG.
• Investors may be optimistic about the company's future prospects or recent advancements in gene editing technology.
• The resilience of CRSP's stock price in the face of a market slip indicates strong investor confidence in the company's potential growth.